MedPage Today puts together a TikTok playlist of Ozempic videos
A TikTok collection of Ozempic clips curated by MedPage Today, listed in Swahili. No details on which videos are included.
Recap by typeshit. Video by TikTok on TikTok.
A TikTok collection of Ozempic clips curated by MedPage Today, listed in Swahili. No details on which videos are included.
Recap by typeshit. Video by TikTok on TikTok.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
The Facebook post says the triple-agonist shot slows stomach emptying, which can be risky under anesthesia. It also notes the drug has no FDA approval yet.
An indirect comparison of trial results presented at EASD found tirzepatide at 10 mg and 15 mg ahead of higher-dose semaglutide on weight loss.
Loading…